Corteva, Inc. (CTVA) came out with quarterly earnings of $2.2 per share, beating the Zacks Consensus Estimate of $1.89 per share. This compares to earnings of $1.83 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +16.40%. A quarter ago, it was expected that this agriculture would post earnings of $0.87 per share when it actually produced earnings of $1.13, delivering a surprise of +29.89%.Over the last four quarters, the compa ...

Snowflake Inc. (SNOW) closed the most recent trading day at $210.54, moving +2.32% from the previous trading session. This move outpaced the S&P 500's daily gain of 0.73%. Meanwhile, the Dow gained 0.18%, and the Nasdaq, a tech-heavy index, added 1.21%. The company's stock has dropped by 7.93% in the past month, falling short of the Computer and Technology sector's gain of 2.75% and the S&P 500's gain of 0.47%.The investment community will be paying close attention to the earnings performance of Snowflake I ...

Immunome, Inc. (IMNM) came out with a quarterly loss of $0.5 per share versus the Zacks Consensus Estimate of a loss of $0.52. This compares to a loss of $0.49 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +3.85%. A quarter ago, it was expected that this company would post a loss of $0.66 per share when it actually produced a loss of $0.52, delivering a surprise of +21.21%.Over the last four quarters, the company has surpass ...

Keros Therapeutics, Inc. (KROS) came out with a quarterly loss of $0.76 per share versus the Zacks Consensus Estimate of a loss of $1.14. This compares to a loss of $1.25 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +33.33%. A quarter ago, it was expected that this company would post a loss of $0.01 per share when it actually produced earnings of $3.62, delivering a surprise of +36300%.Over the last four quarters, the compa ...

CareDx (CDNA) came out with quarterly earnings of $0.1 per share, missing the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.25 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -16.67%. A quarter ago, it was expected that this molecular diagnostics company would post earnings of $0.06 per share when it actually produced earnings of $0.09, delivering a surprise of +50%.Over the last four quarters, t ...

PROCEPT BioRobotics Corporation (PRCT) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to a loss of $0.5 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +14.63%. A quarter ago, it was expected that this company would post a loss of $0.49 per share when it actually produced a loss of $0.45, delivering a surprise of +8.16%.Over the last four quarters, the co ...

Sunrun (RUN) came out with quarterly earnings of $1.07 per share, beating the Zacks Consensus Estimate of a loss of $0.18 per share. This compares to earnings of $0.55 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +694.44%. A quarter ago, it was expected that this solar energy products distributor would post a loss of $0.22 per share when it actually produced earnings of $0.2, delivering a surprise of +190.91%.Over the last ...

Company Performance - Target's stock closed at $105.39, reflecting a +2.89% change from the previous day's closing price, outperforming the S&P 500's daily gain of 0.73% [1] - The upcoming earnings report is scheduled for August 20, 2025, with an expected EPS of $2.08, indicating a 19.07% decline year-over-year, and projected revenue of $24.88 billion, a 2.26% decline compared to the same quarter last year [2] - For the full year, earnings are projected at $7.55 per share and revenue at $104.66 billion, representing declines of -14.79% and -1.79% respectively from the prior year [3] Analyst Estimates and Rankings - Recent adjustments to analyst estimates for Target are crucial as they reflect short-term business trends, with positive revisions indicating analyst optimism [3][4] - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), currently ranks Target at 3 (Hold), with the consensus EPS estimate remaining stagnant over the past month [5] Valuation Metrics - Target has a Forward P/E ratio of 13.57, which is lower than the industry average of 22.5, suggesting that Target is trading at a discount [6] - The company has a PEG ratio of 2.93, compared to the Retail - Discount Stores industry's average PEG ratio of 2.71, indicating a relatively higher valuation when considering expected earnings growth [7] Industry Context - The Retail - Discount Stores industry is part of the Retail-Wholesale sector and holds a Zacks Industry Rank of 79, placing it in the top 32% of over 250 industries [8]

Sarepta Therapeutics (SRPT) came out with quarterly earnings of $2.02 per share, beating the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $0.07 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +81.98%. A quarter ago, it was expected that this biopharmaceutical company would post earnings of $0.35 per share when it actually produced a loss of $3.42, delivering a surprise of -1077.14%.Over the last fo ...

Steris (STE) came out with quarterly earnings of $2.34 per share, beating the Zacks Consensus Estimate of $2.32 per share. This compares to earnings of $2.03 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +0.86%. A quarter ago, it was expected that this medical products maker would post earnings of $2.59 per share when it actually produced earnings of $2.74, delivering a surprise of +5.79%.Over the last four quarters, the com ...